Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 20.92
-0.44 (-2.06%)
At close: Mar 6, 2026
SHA:603896 Market Cap
SHA:603896 has a market cap or net worth of 4.15 billion as of March 6, 2026. Its market cap has increased by 2.65% in one year.
Market Cap
4.15B
Enterprise Value
3.64B
Revenue
642.66M
Ranking
n/a
PE Ratio
30.23
Stock Price
20.92
Market Cap Chart
Since May 10, 2017, SHA:603896's market cap has increased from 2.32B to 4.15B, an increase of 78.49%. That is a compound annual growth rate of 6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.15B | 7.95% |
| Dec 31, 2025 | 3.84B | -8.63% |
| Dec 31, 2024 | 4.20B | -34.21% |
| Dec 29, 2023 | 6.39B | -18.28% |
| Dec 30, 2022 | 7.82B | -11.47% |
| Dec 31, 2021 | 8.83B | 75.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 4.62B |
| Hefei Lifeon Pharmaceutical | 4.62B |
| Beijing Scitop Bio-tech | 4.39B |
| Obio Technology (Shanghai) Corp. | 4.34B |
| Zhejiang Wecome Pharmaceutical Company | 3.98B |
| Hinova Pharmaceuticals | 3.98B |
| Guanhao Biotech | 3.90B |
| Baolingbao Biology | 3.86B |